Stockreport

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026 [Yahoo! Finance]

Kyverna Therapeutics, Inc.  (KYTX) 
PDF Kyverna Therapeutics, Inc. Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS) Oral presenta [Read more]